SII Expands Covovax Paediatric Trial, Aims To Include Kids Aged 2-6

SII will be submitting the interim trial findings on immunogenicity after three months of the advanced clinical trial for licensure

from Top India News- News18.com https://ift.tt/3lgMHMF
via IFTTT